The cluster of C-suite selling at similar prices is a modest bearish signal, but the small percentage of market cap limits material impact. Monitor for any upcoming earnings or corporate events that may have prompted the sales. The stock's strong recent performance (+28% average alpha at T+20 on prior reports) suggests the market may not penalize this activity heavily.
Price Chart
Executive Summary
Four Corcept Therapeutics insiders, including the CEO, CFO, and two other senior executives, sold a total of $5.50M in open-market shares over a one-week window. The sales are concentrated at the C-suite level and represent a material 0.07% of the company's $7.6B market cap. While the dollar amount is modest relative to market cap, the cluster of C-suite selling at similar prices and dates warrants attention, though the sales may be partially explained by option exercises and tax planning.
Key Financial Metrics
Key Facts
- Four insiders sold a total of $5.50M in open-market shares from May 27 to June 1, 2026.
- CEO Joseph Belanoff sold 12,837 shares for $895K at $69.74.
- CFO Atabak Mokari sold 40,000 shares for $2.80M at $70.00.
- Sean Maduck sold 21,069 shares for $1.48M at $70.11.
- Joseph Lyon sold 5,000 shares for $325K at $65.00.
- Total sales represent approximately 0.07% of Corcept's $7.6B market cap.
- All sales occurred near the stock's current price of ~$70, with no significant premium or discount.
- The cluster includes concurrent option exercises and tax-withholding transactions, suggesting some sales may be liquidity-driven.
Financial Impact
Total insider sales of $5.50M, representing 0.07% of market cap.
Risk Factors
- Insider sales may signal management's view that the stock is fairly valued or overvalued near $70.
- The cluster includes option exercises and gifts, which may indicate portfolio diversification rather than a bearish outlook.
- The stock's high analyst bullishness (83% buy ratings) could be contradicted by insider selling.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CORT-1780529126867 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 28, 2026 5w ago | Insider Cluster | $113.88 $115.63 | ▲ +1.54% | ▲ +1.28% | $116.49 (+2.29%) |
Aug 28, 2026 5w ago | Insider Cluster | $113.88 $116.10 | ▲ +1.95% | ▲ +1.44% | $116.49 (+2.29%) |
Aug 27, 2026 5w ago | Insider Cluster | $116.93 $117.00 | ▲ +0.06% | ▲ +0.16% | $116.49 (−0.38%) |
Aug 20, 2026 6w ago | Insider Cluster | $121.05 $114.86 | ▼ −5.11% | ▼ −5.11% | $116.49 (−3.77%) |
Aug 18, 2026 6w ago | Insider Cluster | $118.10 $111.85 | ▲ +5.29% | ▲ +4.30% | $116.49 (+1.36%) |
Aug 12, 2026 7w ago | Insider Cluster | $112.18 $114.92 | ▲ +2.44% | ▲ +4.34% | $116.49 (+3.84%) |
Aug 12, 2026 7w ago | Insider Cluster | $112.18 $114.92 | ▲ +2.44% | ▲ +4.34% | $116.49 (+3.84%) |
Aug 6, 2026 8w ago | Insider Cluster | $110.77 $111.62 | ▲ +0.77% | ▲ +1.16% | $116.49 (+5.16%) |
Aug 5, 2026 8w ago | Insider Cluster | $107.95 $112.80 | ▲ +4.49% | ▲ +3.89% | $116.49 (+7.91%) |
Jul 23, 2026 10w ago | Court Ruling | $96.66 $121.05 | ▲ +25.23% | ▲ +21.92% | $116.49 (+20.52%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access